[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (2,549)

Search Parameters:
Keywords = hyperglycemia

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
26 pages, 1014 KiB  
Article
Evaluation of Selected Pro- and Anti-Inflammatory Adipokines in Colostrum from Mothers with Gestational Diabetes Mellitus
by Jolanta Lis-Kuberka, Marta Berghausen-Mazur and Magdalena Orczyk-Pawiłowicz
Int. J. Mol. Sci. 2025, 26(1), 40; https://doi.org/10.3390/ijms26010040 - 24 Dec 2024
Abstract
Adipokines related to gestational diabetes mellitus (GDM) are an emerging area of interest. The aim of this study was to evaluate the associations between GDM and adipokine levels in human milk. This was an observational cohort study targeting mothers with gestational diabetes, which [...] Read more.
Adipokines related to gestational diabetes mellitus (GDM) are an emerging area of interest. The aim of this study was to evaluate the associations between GDM and adipokine levels in human milk. This was an observational cohort study targeting mothers with gestational diabetes, which evaluated the association of maternal hyperglycemia severity, classified as GDM-G1 (diet treatment) and GDM-G2 (insulin treatment), with colostral adipokines involved in pro- and anti-inflammatory processes. Colostrum was collected from hyperglycemic (N = 34) and normoglycemic (N = 26) mothers, and adipokine levels were determined by immunoenzymatic assay. Among anti-inflammatory adipokines, only for irisin and vaspin, but not for obestatin and adropin, were significantly different levels noted between the GDM-G1, GDM-G2 and non-GDM cohorts. Colostrum of the GDM-G2 subgroup contained more vaspin (4.77 ng/mL) than that of normoglycemic mothers (3.12 ng/mL) and more irisin (26.95 μg/mL) than in the GDM-G1 subgroup (17.59 μg/mL). The levels of pro-inflammatory adipokines, namely, dermcidin, chemerin and visfatin, were at similar levels irrespective of maternal glycemia. Moreover, irisin showed a negative correlation with dermcidin in GDM-G2 and non-GDM cohorts. Associations were observed between colostral irisin and maternal preconception BMI, dermcidin and gestational age, and vaspin and maternal age. This study provides evidence that the way of restoring glucose homeostasis in pregnant women has an impact on the anti-inflammatory adipokines irisin and vaspin, but not on obestatin and adropin. GDM, regardless of severity, did not influence the colostral pro-inflammatory adipokines visfatin, chemerin and dermcidin. Full article
(This article belongs to the Special Issue Molecular Advances in Gestational Diabetes Mellitus)
Show Figures

Figure 1

Figure 1
<p>Comparison of irisin (<b>A</b>), adropin (<b>B</b>), obestatin (<b>C</b>), visfatin (<b>D</b>), vaspin (<b>E</b>), chemerin (<b>F</b>) and dermcidin (<b>G</b>) concentrations in colostrum between gestational diabetic (G1 and G2) and normoglycemic (non-GDM) mothers. Data are given as mean and median values and 25th and 75th quartiles. A <span class="html-italic">p</span>-value lower than 0.05 was regarded as significant.</p>
Full article ">Figure 2
<p>Correlations between the concentration of adipokine in milk collected from GDM and non-GDM mothers and day of lactation, age, preconceptional BMI, and week of gestation. The Spearman correlation coefficient is represented in the heat map following the color in the legend. BMI—preconceptional body mass index; HBD—week of gestation. Bold frames represent correlations with statistical significance (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">
13 pages, 4334 KiB  
Article
Effects of Metabolites Derived from Guava (Psidium guajava L.) Leaf Extract Fermented by Limosilactobacillus fermentum on Hepatic Energy Metabolism via SIRT1-PGC1α Signaling in Diabetic Mice
by Sohyun Jeon, Heaji Lee, Sun-Yeou Kim, Choong-Hwan Lee and Yunsook Lim
Nutrients 2025, 17(1), 7; https://doi.org/10.3390/nu17010007 - 24 Dec 2024
Abstract
Background/Objectives: Type 2 diabetes mellitus (T2DM) is considered a serious risk to public health since its prevalence is rapidly increasing worldwide despite numerous therapeutics. Insulin resistance in T2DM contributes to chronic inflammation and other metabolic abnormalities that generate fat accumulation in the liver, [...] Read more.
Background/Objectives: Type 2 diabetes mellitus (T2DM) is considered a serious risk to public health since its prevalence is rapidly increasing worldwide despite numerous therapeutics. Insulin resistance in T2DM contributes to chronic inflammation and other metabolic abnormalities that generate fat accumulation in the liver, eventually leading to the progression of metabolic dysfunction-associated fatty liver disease (MAFLD). Recently, the possibility that microbial-derived metabolites may alleviate MAFLD through enterohepatic circulation has emerged, but the underlying mechanism remains unclear. In this research, we utilized metabolites obtained from the fermentation of guava leaf extract, which is well-known for its antidiabetic activity, to investigate their effects and mechanisms on MAFLD. Methods: Diabetes was induced by a high-fat diet and streptozotocin injection (80 mg/kg body weight) twice in mice. Subsequently, mice whose fasting blood glucose levels were measured higher than 300 mg/dL were administered with metabolites of Limosilactobacillus fermentum (LF) (50 mg/kg/day) or guava leaf extract fermented by L. fermentum (GFL) (50 mg/kg/day) by gavage for 15 weeks. Results: GFL supplementation mitigated hyperglycemia and hepatic insulin resistance. Moreover, GFL regulated abnormal hepatic histological changes and lipid profiles in diabetic mice. Furthermore, GFL enhanced energy metabolism by activating the sirtuin1 (SIRT1)/proliferator-activated receptor γ coactivator 1α (PGC1α)/peroxisome proliferator-activated receptor (PPAR)-α pathway in diabetic mice. Meanwhile, GFL supplementation suppressed hepatic inflammation in diabetic mice. Conclusions: Taken together, the current study elucidated that GFL could be a potential therapeutic to ameliorate hyperglycemia and hepatic steatosis by improving SIRT1/PGC-1α/ PPAR-α-related energy metabolism in T2DM. Full article
(This article belongs to the Section Nutrition and Diabetes)
Show Figures

Figure 1

Figure 1
<p>GFL supplementation decreased (<b>A</b>) fasting blood glucose and (<b>B</b>) hemoglobin A1c (HbA1c) levels in diabetic mice. All values above are represented as mean ± SD (n = 5–6). Means with different letters were significantly different. A <span class="html-italic">p</span>-value &lt; 0.05 was considered statistically significant.</p>
Full article ">Figure 2
<p>GFL supplementation alleviated (<b>A</b>) hepatic morphology (200× magnification) in diabetic mice. (<b>B</b>) % lipid droplet, (<b>C</b>) average lipid droplet size, and (<b>D</b>) the number of lipid droplets. All values above are represented as mean ± SD (n = 3). Means with different letters were significantly different. A <span class="html-italic">p</span>-value &lt; 0.05 was considered statistically significant.</p>
Full article ">Figure 3
<p>GFL supplementation mitigated hepatic lipid profiles in diabetic mice. (<b>A</b>) triglyceride content and (<b>B</b>) total cholesterol content All values above are represented as mean ± SD (n = 5–6). Means with different letters were significantly different. A <span class="html-italic">p</span>-value &lt; 0.05 was considered statistically significant.</p>
Full article ">Figure 4
<p>GFL supplementation improved hepatic insulin signaling in diabetic mice. All values above are represented as mean ± SD (n = 5–6). Means with different letters were significantly different. A <span class="html-italic">p</span>-value &lt; 0.05 was considered statistically significant.</p>
Full article ">Figure 5
<p>GFL supplementation reduced hepatic lipogenesis in diabetic mice. All values above are represented as mean ± SD (n = 5–6). Means with different letters were significantly different. A <span class="html-italic">p</span>-value &lt; 0.05 was considered statistically significant.</p>
Full article ">Figure 6
<p>GFL supplementation enhanced hepatic energy metabolism in diabetic mice. All values above are represented as mean ± SD (n = 5–6). Means with different letters were significantly different. A <span class="html-italic">p</span>-value &lt; 0.05 was considered statistically significant.</p>
Full article ">Figure 7
<p>GFL supplementation attenuated hepatic inflammation in diabetic mice. All values above are represented as mean ± SD (n = 5–6). Means with different letters were significantly different. A <span class="html-italic">p</span>-value &lt; 0.05 was considered statistically significant.</p>
Full article ">
12 pages, 702 KiB  
Review
Benefits of Cilostazol’s Effect on Vascular and Neuropathic Complications Caused by Diabetes
by Diego Castro Musial, Maria Eduarda Ajita and Guilherme Henrique Souza Bomfim
Med. Sci. 2025, 13(1), 1; https://doi.org/10.3390/medsci13010001 - 24 Dec 2024
Abstract
Diabetes mellitus (DM) is a global health concern with a rising incidence, particularly in aging populations and those with a genetic predisposition. Over time, DM contributes to various complications, including nephropathy, retinopathy, peripheral arterial disease (PAD), and neuropathy. Among these, diabetic neuropathy and [...] Read more.
Diabetes mellitus (DM) is a global health concern with a rising incidence, particularly in aging populations and those with a genetic predisposition. Over time, DM contributes to various complications, including nephropathy, retinopathy, peripheral arterial disease (PAD), and neuropathy. Among these, diabetic neuropathy and PAD stand out due to their high prevalence and significant impact on patients’ quality of life. Diabetic distal symmetric polyneuropathy, the most common form of diabetic neuropathy, is driven by neuroinflammation stemming from prolonged hyperglycemia. Simultaneously, hyperglycemia significantly increases the risk of PAD, a condition further exacerbated by factors like smoking, age, and sedentary lifestyles. PAD frequently manifests as claudication, a debilitating symptom marked by pain and cramping during physical activity, which limits mobility and worsens patients’ outcomes. Cilostazol, a phosphodiesterase-3 inhibitor, has proven effective in managing intermittent claudication in PAD by improving walking distances and enhancing blood flow. Recent studies have also explored its potential benefits for diabetic neuropathy. Cilostazol’s mechanisms include vasodilation, platelet inhibition, and increased cyclic adenosine monophosphate (cAMP) levels, which may contribute to improved neurological outcomes. However, variability in the clinical evidence due to inconsistent treatment protocols highlights the need for further investigation. This review explores cilostazol’s mechanisms of action and therapeutic applications for managing neuropathy and PAD in diabetic patients, aiming to provide insights into its potential as a dual-purpose pharmacological agent in this high-risk population. Full article
Show Figures

Figure 1

Figure 1
<p>Mechanism of action of cilostazol and its therapeutic potential in the treatment of diabetic neuropathy.</p>
Full article ">Figure 2
<p>A scheme showing the entry of glucose into the endothelial cells, mediated by the GLUT1 and GLUT3 glucose transporters. Upon entering the cell, excess glucose stimulates an increase in oxidative stress and the activation of advanced glycation end products (AGEs), resulting in an increase in intracellular signaling, stimulating factors that generate inflammation, which contributes to the atherogenesis process.</p>
Full article ">
18 pages, 1423 KiB  
Review
Pro-Health Potential of Fruit Vinegars and Oxymels in Various Experimental Models
by Beata Olas
Int. J. Mol. Sci. 2025, 26(1), 7; https://doi.org/10.3390/ijms26010007 - 24 Dec 2024
Abstract
Fruits are excellent sources of substrate for various fermented products, including fruit vinegars, which are typically produced by submerged fermentation. Some evidence suggests that fruit vinegar consumption can alleviate certain disorders, including hyperlipidemia, inflammation, and hyperglycemia. Fruit vinegars also have bacteriostatic and antihypertensive [...] Read more.
Fruits are excellent sources of substrate for various fermented products, including fruit vinegars, which are typically produced by submerged fermentation. Some evidence suggests that fruit vinegar consumption can alleviate certain disorders, including hyperlipidemia, inflammation, and hyperglycemia. Fruit vinegars also have bacteriostatic and antihypertensive actions. Recent studies also suggest that apple vinegar may offer benefits in treating insulin resistance, osteoporosis, and certain neurological diseases such as Alzheimer’s disease; it may also support weight loss. Recent studies in animal and human models have considerably broadened our understanding of the biological properties of not only fruit vinegars but also oxymels, i.e., mixtures of vinegar and honey or sugar. This paper reviews the current state of knowledge regarding vinegars and oxymels, with a special emphasis on their chemical composition and the mechanisms behind their biological activity and pro-health potential. The multidirectional effects of fruit vinegars and oxymels result from the synergy of different chemical compounds, including organic acids (mainly acetic acid), phenolic compounds, vitamins, minerals, and fermentation products. However, more studies are needed to understand the interactions between all the different components, not only the phenolic compounds and organic acids. In addition, more research is needed on their mechanisms of action. Although no serious side effects have been noted to date, further studies with large sample sizes are needed to understand the possible side effects of long-term fruit vinegar and oxymel use. Full article
(This article belongs to the Section Bioactives and Nutraceuticals)
Show Figures

Figure 1

Figure 1
<p>Chemical characteristic of fruit vinegars.</p>
Full article ">Figure 2
<p><b>Biological properties of fruit vinegars and their potential molecular mechanisms.</b> AMPK, 5′AMP-activated protein kinase; AT1R, angiotensin II receptor type 1; COX, cyclooxygenase; GFAP, glial fibrillary acidic protein; Il, interleukin; Iba-1, ionized calcium-binding adapter molecule-1; iNOS, inducible nitric oxide synthase; MAO, monoamine oxidase; MAPK, mitogen-activated protein kinase; PPAR, peroxisome proliferators-activated receptors; TNF-α, tumor necrosis factor-α.</p>
Full article ">
10 pages, 750 KiB  
Article
Predictors of Postprandial Hyperglycemia in Non-Diabetic Adult Hospital Visitors: A Cross-Sectional Study Across Religious Groups in Northern Israel
by Amir Bashkin, Osnat Sharon, Anita Zur and Afif Nakhleh
J. Clin. Med. 2024, 13(24), 7866; https://doi.org/10.3390/jcm13247866 - 23 Dec 2024
Abstract
Background/Objectives: Ethnocultural differences between Jewish and Arab communities in Northern Israel may contribute to disparities in type 2 diabetes prevalence. Widespread screening strategies, including hospital-based initiatives, are crucial for early detection of hyperglycemia. This study aimed to determine the prevalence of postprandial hyperglycemia [...] Read more.
Background/Objectives: Ethnocultural differences between Jewish and Arab communities in Northern Israel may contribute to disparities in type 2 diabetes prevalence. Widespread screening strategies, including hospital-based initiatives, are crucial for early detection of hyperglycemia. This study aimed to determine the prevalence of postprandial hyperglycemia and identify its associated factors in a diverse population of non-diabetic adults visiting the Galilee Medical Center, a tertiary care hospital in Northern Israel. Methods: Participants were recruited between November 2017 and July 2023 through a voluntary screening program for non-diabetic adult visitors to the hospital. Capillary blood glucose measurements were obtained 1–4 h after a meal using a standardized glucometer. Postprandial hyperglycemia was defined as a blood glucose level ≥147 mg/dL, while postprandial normoglycemia was defined as ≤133 mg/dL. Individuals with glucose levels between 134–146 mg/dL were excluded from the analysis. Additional exclusion criteria included known diabetes, acute illness, corticosteroid use, and pregnancy. Demographic data, lifestyle factors, and health status were recorded. Propensity score matching was employed to ensure comparability between religious groups based on age, gender, and body mass index. Logistic regression analyses were conducted to identify independent predictors of postprandial hyperglycemia. Results: 3457 adult visitors underwent postprandial glucose testing and met eligibility criteria. Following propensity score matching, 1845 participants (615 each from Druze, Jewish, and Muslim religious groups) were included in the final analysis. The prevalence of postprandial hyperglycemia was 9.4% in Druze, 6.0% in Jews, and 8.0% in Muslims (p = 0.08). Age >50 years was significantly associated with postprandial hyperglycemia in all groups. Obesity was associated with postprandial hyperglycemia in Muslims, with a similar non-significant trend in the Jewish cohort. Self-reported poor health was also associated with postprandial hyperglycemia in Muslims. In the Druze cohort, a low daily intake of daily fresh vegetable consumption was significantly associated with postprandial hyperglycemia. Conclusions: This study highlights the feasibility of hospital-based screening for postprandial hyperglycemia among adult visitors and reveals ethnic variations in prevalence and associated risk factors. Full article
Show Figures

Figure 1

Figure 1
<p>Flow diagram of subjects included in the study. Abbreviations: PS, propensity score.</p>
Full article ">
15 pages, 2977 KiB  
Article
Jeju Citrus (Citrus unshiu) Leaf Extract and Hesperidin Inhibit Small Intestinal α-Glucosidase Activities In Vitro and Postprandial Hyperglycemia in Animal Model
by Gi-Jung Kim, Yelim Jang, Kyoung-Tae Kwon, Jae-Won Kim, Seong-IL Kang, Hee-Chul Ko, Jung-Yun Lee, Emmanouil Apostolidis and Young-In Kwon
Int. J. Mol. Sci. 2024, 25(24), 13721; https://doi.org/10.3390/ijms252413721 - 23 Dec 2024
Abstract
Citrus fruits are widely distributed in East Asia, and tea made from citrus peels has demonstrated health benefits, such as a reduction in fever, inflammation, and high blood pressure. However, citrus leaves have not been evaluated extensively for their possible health benefits. In [...] Read more.
Citrus fruits are widely distributed in East Asia, and tea made from citrus peels has demonstrated health benefits, such as a reduction in fever, inflammation, and high blood pressure. However, citrus leaves have not been evaluated extensively for their possible health benefits. In this study, the α-glucosidase-inhibitory activity of Jeju citrus hot-water (CW) and ethyl alcohol (CE) extracts, along with hesperidin (HP) (a bioactive compound in citrus leaf extracts), was investigated, and furthermore, their effect on postprandial blood glucose reduction in an animal model was determined. The hesperidin contents of CW and CE were 15.80 ± 0.18 and 39.17 ± 0.07 mg/g-extract, respectively. Hesperidin inhibited α-glucosidase (IC50, 4.39), sucrase (0.50), and CE (2.62) and demonstrated higher α-glucosidase inhibitory activity when compared to CW (4.99 mg/mL). When using an SD rat model, during sucrose and starch loading tests with CE (p < 0.01) and HP (p < 0.01), a significant postprandial blood glucose reduction effect was observed when compared to the control. The maximum blood glucose levels (Cmax) of the CE administration group decreased by about 15% (from 229.3 ± 14.5 to 194.0 ± 7.4, p < 0.01) and 11% (from 225.1 ± 13.8 to 201.1 ± 7.2 hr·mg/dL, p < 0.05) in the sucrose and starch loading tests, respectively. Our findings suggest that citrus leaf extracts standardized to hesperidin may reduce postprandial blood glucose levels through the observed inhibitory effect against sucrase, which results in delayed carbohydrate absorption. Our findings provide a biochemical rationale for further evaluating the benefits of citrus leaves. Full article
(This article belongs to the Special Issue Bioactive Phenolics and Polyphenols 2024)
Show Figures

Figure 1

Figure 1
<p>Chemical structure of hesperidin.</p>
Full article ">Figure 2
<p>HPLC profiles of citrus leaf extracts (standard solution (<b>a</b>), hot-water extract (<b>b</b>), and ethyl alcohol extract (<b>c</b>)). 1. Rutin; 2. Neoeriocitrin; 3. Narirutin; 4. Rhoifolin; 5. Naringin; 6. Hesperidin; 7. Neohesperidin; 8. Neoponcirin; 9. Poncirin; 10. Naringenin; 11. Hesperetin; 12. Isosinensetin; 13. Sinensetin; 14. 4,5,7-Trimethoxy flavon; 15. Nobiletin; 16. 4,5,6,7-Tetramethoxy flavon; 17. Tangeretin; 18. 5-Demethyl nobiletin; and 19. Gardenin B.</p>
Full article ">Figure 2 Cont.
<p>HPLC profiles of citrus leaf extracts (standard solution (<b>a</b>), hot-water extract (<b>b</b>), and ethyl alcohol extract (<b>c</b>)). 1. Rutin; 2. Neoeriocitrin; 3. Narirutin; 4. Rhoifolin; 5. Naringin; 6. Hesperidin; 7. Neohesperidin; 8. Neoponcirin; 9. Poncirin; 10. Naringenin; 11. Hesperetin; 12. Isosinensetin; 13. Sinensetin; 14. 4,5,7-Trimethoxy flavon; 15. Nobiletin; 16. 4,5,6,7-Tetramethoxy flavon; 17. Tangeretin; 18. 5-Demethyl nobiletin; and 19. Gardenin B.</p>
Full article ">Figure 3
<p>Dose-dependent changes in SD rat small intestinal α-glucosidase-inhibitory activity (% inhibition) of GO2KA1 (GO), Jeju citrus leaf hot-water extract (CW), Jeju citrus leaf ethyl alcohol extract (CE), and hesperidin (HP). Different corresponding letters indicate significant differences at <span class="html-italic">p</span> &lt; 0.05 by Duncan’s test. <sup>a–d</sup> First letter indicates differences among different samples, and <sup>A–C</sup> second one indicates differences among different concentrations of same samples.</p>
Full article ">Figure 4
<p>Dose-dependent changes in SD rat small intestinal sucrase-inhibitory activity (% inhibition) of GO2KA1 (GO), Jeju citrus leaf hot-water extract (CW), Jeju citrus leaf ethyl alcohol extract (CE), and hesperidin (HP). Different corresponding letters indicate significant differences at <span class="html-italic">p</span> &lt; 0.05 by Duncan’s test. <sup>a–c</sup> First letter indicates differences among different samples, and <sup>A–C</sup> second one indicates differences among different concentrations of same samples.</p>
Full article ">Figure 5
<p>Dose-dependent changes in SD rat small intestinal maltase-inhibitory activity (% inhibition) of GO2KA1 (GO), Jeju citrus leaf hot-water extract (CW), Jeju citrus leaf ethyl alcohol extract (CE), and hesperidin (HP). Different corresponding letters indicate significant differences at <span class="html-italic">p</span> &lt; 0.05 by Duncan’s test. <sup>a–c</sup> First letter indicates differences among different samples, and <sup>A–D</sup> second one indicates differences among different concentrations of same samples.</p>
Full article ">Figure 6
<p>Dose-dependent changes in SD rat small intestinal glucoamylase-inhibitory activity (% inhibition) of GO2KA1 (GO), Jeju citrus leaf hot-water extract (CW), Jeju citrus leaf ethyl alcohol extract (CE), and hesperidin (HP). Different corresponding letters indicate significant differences at <span class="html-italic">p</span> &lt; 0.05 by Duncan’s test. <sup>a–c</sup> First letter indicates differences among different samples, and <sup>A–D</sup> second one indicates differences among different concentrations of same samples.</p>
Full article ">Figure 7
<p>Dose-dependent anti-hyperglycemic effect of ethyl alcohol extracts of citrus leaves (CE) in sucrose loading test. After fasting for 24 h, 5-week-old male SD rats were orally administered sucrose solution (2.0 g/kg-body weight (b.w.)) with or without samples (CE 0.1 g/kg-b.w., CE 0.5 g/kg-b.w., and positive control: GO2KA1 0.5 g/kg-b.w.). Each point represents mean ± standard deviation (<span class="html-italic">n</span> = 10). ** <span class="html-italic">p</span> &lt; 0.01 and *** <span class="html-italic">p</span> &lt; 0.001 compared to different samples at the same concentration by unpaired Student’s <span class="html-italic">t</span>-test.</p>
Full article ">Figure 8
<p>The dose-dependent anti-hyperglycemic effect of hesperidin (HP) on sucrose loading test results. After fasting for 24 h, 5-week-old male SD rats were orally administered a sucrose solution (2.0 g/kg-body weight (b.w.)) with or without the test samples (HP 0.1 g/kg-b.w. and HP 0.5 g/kg-b.w.). Each point represents mean ± standard deviation (<span class="html-italic">n</span> = 10). <span class="html-italic">*** p</span> &lt; 0.001 compared to different samples at the same concentration by unpaired Student’s <span class="html-italic">t</span>-test.</p>
Full article ">Figure 9
<p>The dose-dependent anti-hyperglycemic effect of ethyl alcohol extracts of citrus leaves (CE) on starch loading test results. After fasting for 24 h, 5-week-old male SD rats were orally administered a starch solution (2.0 g/kg-body weight (b.w.)) with or without samples (CE 0.1 g/kg-b.w., CE 0.5 g/kg-b.w., and positive control: GO2KA1 0.5 g/kg-b.w.). Each point represents mean ± standard deviation (<span class="html-italic">n</span> = 10). <span class="html-italic">* p</span> &lt; 0.05 and <span class="html-italic">*** p</span> &lt; 0.001 compared to different samples at the same concentration by unpaired Student’s <span class="html-italic">t</span>-test.</p>
Full article ">Figure 10
<p>The dose-dependent anti-hyperglycemic effect of hesperidin (HP) on starch loading test results. After fasting for 24 h, 5-week-old male SD rats were orally administered a starch solution (2.0 g/kg-body weight (b.w.)) with or without samples (HP 0.1 g/kg-b.w. and HP 0.5 g/kg-b.w.). Each point represents mean ± standard deviation (<span class="html-italic">n</span> = 10). <span class="html-italic">*** p</span> &lt; 0.001 compared to different samples at the same concentration by unpaired Student’s <span class="html-italic">t</span>-test.</p>
Full article ">
20 pages, 8907 KiB  
Article
Proline Improves Pullulan Biosynthesis Under High Sugar Stress Condition
by Keyi Liu, Junqing Wang, Feng Li, Ruiming Wang, Qingming Zeng, Zhenxing Zhang, Hongwei Liu and Piwu Li
Microorganisms 2024, 12(12), 2657; https://doi.org/10.3390/microorganisms12122657 - 21 Dec 2024
Viewed by 255
Abstract
Pullulan is an extracellular polysaccharide produced via the fermentation of Aureobasidium pullulans. However, high sugar concentrations and hyperosmotic stress limit pullulan biosynthesis during the fermentation process. Therefore, we investigated the effects of proline supplementation on A. pullulans growth and pullulan biosynthesis [...] Read more.
Pullulan is an extracellular polysaccharide produced via the fermentation of Aureobasidium pullulans. However, high sugar concentrations and hyperosmotic stress limit pullulan biosynthesis during the fermentation process. Therefore, we investigated the effects of proline supplementation on A. pullulans growth and pullulan biosynthesis under high sugar and hyperosmotic stress using physiological, biochemical, and transcriptomic analyses. High sugar concentrations significantly inhibited A. pullulans growth and pullulan biosynthesis. High sugar and hyperosmotic stress conditions significantly increased intracellular proline content in A. pullulans. However, treatment with proline (400 mg/L proline) significantly increased biomass and pullulan yield by 10.75% and 30.06% (174.8 g/L), respectively, compared with those in the control group. To further investigate the effect of proline on the fermentation process, we performed scanning electron microscopy and examined the activities of key fermentation enzymes. Proline treatment preserved cell integrity and upregulated the activities of key enzymes involved in pullulan biosynthesis. Transcriptome analysis revealed that most differentially expressed genes in the proline group were associated with metabolic pathways, including glycolysis/gluconeogenesis, pyruvate metabolism, and sulfur metabolism. Conclusively, proline supplementation protects A. pullulans against high sugar and hyperosmotic stress, providing a new theoretical basis and strategy for the efficient industrial production of pullulans. Full article
(This article belongs to the Special Issue Advances in Metabolic Engineering of Industrial Microorganisms)
Show Figures

Figure 1

Figure 1
<p>Effect of different sugar concentrations on pullulan production and <span class="html-italic">Aureobasidium pullulans</span> growth: Pullulan yield (<b>a</b>); cell biomass (<b>b</b>).</p>
Full article ">Figure 2
<p>Changes in the contents of glutamic acid, glycine, and proline under different sucrose concentrations were evaluated. Significant differences (<span class="html-italic">p</span> &lt; 0.05) were determined using a one-way analysis of variance with Duncan’s test and represented using different letters.</p>
Full article ">Figure 3
<p>Effects of exogenous supplementation of glutamic acid, glycine, and proline on biomass (<b>a</b>) and pullulan yield (<b>b</b>) under high sugar conditions (200 g/L) and on biomass (<b>c</b>) and pullulan yield (<b>d</b>) under low sugar conditions (100 g/L). Significant differences (<span class="html-italic">p</span> &lt; 0.05) were determined using a one-way analysis of variance with Duncan’s test and represented using different letters.</p>
Full article ">Figure 4
<p>Effect of exogenous proline on proline (<b>a</b>) and glycerol (<b>b</b>) concentration in <span class="html-italic">Aureobasidium pullulans</span> cells at different sucrose concentrations (100 and 200 g/L).</p>
Full article ">Figure 5
<p>Comparative analysis of scanning electron microscopy images of the experimental and control groups in the absence of proline: (<b>a</b>) Control cells, magnification: 10,000×. (<b>b</b>) Control cells, magnification: 2500×. (<b>c</b>) Cells in the experimental group, magnification: 10,000×. (<b>d</b>) Cells in the experimental group, magnification: 2500×.</p>
Full article ">Figure 6
<p>Activities of pullulan biosynthetic and degrading enzymes in the experimental and control groups in the presence or absence of proline at different fermentation stages. UGP: UDP–glucose pyrophosphorylase (<b>a</b>); PGM: α-phosphoglucomutase (<b>b</b>); UGT: UDP–glucosyltransferase (<b>c</b>); AMY: α-amylase (<b>d</b>); IPU: isopullulanase (<b>e</b>). Asterisks indicate the level of significance using the Student’s <span class="html-italic">t</span>-test (* <span class="html-italic">p</span>  &lt;  0.05; ** <span class="html-italic">p</span>  &lt;  0.01) in comparison to the control without proline addition.</p>
Full article ">Figure 7
<p>Sample correlation heat map (<b>a</b>). Statistics of differentially expressed genes (DEGs) (<b>b</b>). Volcano plot (<b>c</b>) and heatmap (<b>d</b>) showing gene expression patterns in the control (CK) and proline (CP) groups. CK: <span class="html-italic">Aureobasidium pullulans</span> cultivated for 24 h in the initial fermentation medium; CP: <span class="html-italic">A</span>. <span class="html-italic">pullulans</span> cultivated for 24 h in the fermentation medium containing proline. In the volcano plot of differential genes, each point represents a gene, with red representing upregulation and blue representing downregulation. In the differential comparison clustering heat map, the expression levels of genes in different samples are represented by different colors.</p>
Full article ">Figure 8
<p>Gene ontology (GO) enrichment circle diagram (<b>a</b>): The first circle represents the top 20 enriched GO terms, the second circle represents the number and Q value of the GO term in the background of differential genes, and the third circle represents the proportion of upregulated and downregulated DEGs. GO enrichment difference bubble chart (<b>b</b>): The ordinate is -log10 (Q value), and the abscissa is the z-score value. GO enrichment classification histogram (<b>c</b>): abscissa is the secondary GO term, ordinate is the number of differential genes in the term, and different colors represent different types of GO terms.</p>
Full article ">Figure 8 Cont.
<p>Gene ontology (GO) enrichment circle diagram (<b>a</b>): The first circle represents the top 20 enriched GO terms, the second circle represents the number and Q value of the GO term in the background of differential genes, and the third circle represents the proportion of upregulated and downregulated DEGs. GO enrichment difference bubble chart (<b>b</b>): The ordinate is -log10 (Q value), and the abscissa is the z-score value. GO enrichment classification histogram (<b>c</b>): abscissa is the secondary GO term, ordinate is the number of differential genes in the term, and different colors represent different types of GO terms.</p>
Full article ">Figure 9
<p>Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment circle diagram (<b>a</b>): The first circle represents the top 20 enriched pathways, the second circle represents the number and Q value of the pathway, and the third circle represents the proportion of upregulated and downregulated DEGs. KEGG enrichment difference bubble chart (<b>b</b>): The ordinate is −log10 (Q value), and the abscissa is the z-score value. KEGG enrichment secondary classification histogram (<b>c</b>): the top 20 KEGG enriched pathways.</p>
Full article ">Figure 9 Cont.
<p>Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment circle diagram (<b>a</b>): The first circle represents the top 20 enriched pathways, the second circle represents the number and Q value of the pathway, and the third circle represents the proportion of upregulated and downregulated DEGs. KEGG enrichment difference bubble chart (<b>b</b>): The ordinate is −log10 (Q value), and the abscissa is the z-score value. KEGG enrichment secondary classification histogram (<b>c</b>): the top 20 KEGG enriched pathways.</p>
Full article ">
7 pages, 614 KiB  
Case Report
Examining Emphysematous Pyelonephritis: A Case Study on Diagnosis and Outcomes
by Mahnoor Mahnoor, Syeda Aina Ali, Saira Nasir, Moiz Azmat and Hafiz Muhammad Umer Farooqi
Emerg. Care Med. 2024, 1(4), 454-460; https://doi.org/10.3390/ecm1040045 - 21 Dec 2024
Viewed by 365
Abstract
Background: Emphysematous pyelonephritis (EPN) is an infectious disease of the renal system caused by gas-producing microorganisms harboring the kidneys. Patients with diabetes mellitus (DM), an endocrine disease with hyperglycemia, are particularly susceptible to the EPN as their immune system is compromised in [...] Read more.
Background: Emphysematous pyelonephritis (EPN) is an infectious disease of the renal system caused by gas-producing microorganisms harboring the kidneys. Patients with diabetes mellitus (DM), an endocrine disease with hyperglycemia, are particularly susceptible to the EPN as their immune system is compromised in fighting against infections. Case Description: We present a case of a 50-year-old female with a history of chronic diabetes and persistent hypertension. She presented with symptoms of pyrexia and flank pain. Following findings from ultrasound, she was advised to undergo computed tomographic (CT) scans that reveal air-filled hypodense areas at the upper and mid pole of the right kidney and in the renal pelvis of the right ureter, which confirms the class I EPN in the patient. Urine culture identifies Escherica coli as the causative agent for EPN. The patient was managed with third-generation antibiotics over two weeks, leading to full recovery without surgical intervention. Discussion: The availability of CT imaging makes early diagnosis and reduces mortality associated with EPN. Conservative medical management should be the initial treatment strategy for EPN. However, severe cases require immediate therapeutic action. In our case, the patient was treated with antibiotic therapy and recovered. Conclusions: CT scan seems to be the optimal diagnosis in patients with acute emphysematous pyelonephritis. Patients with EPN class I respond well to medical treatment with excellent outcomes. Full article
Show Figures

Figure 1

Figure 1
<p>Axial view of CT image showing multiple air-filled hypodense areas in the right kidney (yellow arrow), confirming type I EPN. (<b>a</b>) Upper and mid-pole. (<b>b</b>) Renal pelvis of the right kidney and right ureter.</p>
Full article ">Figure 2
<p>Sagittal view of CT image showing multiple air-filled hypodense areas in the right kidney (yellow arrow), confirming type I EPN.</p>
Full article ">
5 pages, 1712 KiB  
Proceeding Paper
Evaluation of a Continuous Blood Glucose Sensor’s Performance for Hospitalized Patients
by Ruiqi Lim, James Ven Wee Yap, Siti Rafeah Mohamed Rafei and Ming-Yuan Cheng
Eng. Proc. 2024, 78(1), 5; https://doi.org/10.3390/engproc2024078005 - 20 Dec 2024
Abstract
Frequent blood glucose monitoring is crucial for managing blood glucose levels in critically ill hospitalized patients experiencing hyperglycemia or hypoglycemia. Existing blood glucose monitoring methods are often cumbersome, painful, and impractical for hourly testing. This work provides a solution for frequent glucose monitoring [...] Read more.
Frequent blood glucose monitoring is crucial for managing blood glucose levels in critically ill hospitalized patients experiencing hyperglycemia or hypoglycemia. Existing blood glucose monitoring methods are often cumbersome, painful, and impractical for hourly testing. This work provides a solution for frequent glucose monitoring (less than 1 h per test) for hospitalized patients, ensuring accuracy while minimizing discomfort from blood collection. The glucose sensor demonstrated accuracy within 10% across a range of 0–20 mM over 96 testing cycles. This meets the need for hourly monitoring during an average 2-day hospital stay. Full article
Show Figures

Figure 1

Figure 1
<p>Schematic of blood glucose sensing module.</p>
Full article ">Figure 2
<p>Fabrication and bonding process for glucose sensing module. (1) Master mold, (2) PDMS molding, (3) PDMS released from mold, (4) PDMS inlet drilling, (5) Plasma surface treatment, (6) Sample bonding.</p>
Full article ">Figure 3
<p>Assembled glucose sensing module.</p>
Full article ">Figure 4
<p>Glucose sensor benchtop characterization results: (<b>a</b>) current output related to glucose concentration based on the testing procedure steps; (<b>b</b>) average current output vs. concentration.</p>
Full article ">Figure 5
<p>Glucose sensor durability testing results.</p>
Full article ">
20 pages, 5471 KiB  
Systematic Review
Relevant Serum Endoplasmic Reticulum Stress Biomarkers in Type 2 Diabetes and Its Complications: A Systematic Review and Meta-Analysis
by José Rafael Villafan-Bernal, Francisco Barajas-Olmos, Iris Paola Guzmán-Guzmán, Angélica Martínez-Hernández, Cecilia Contreras-Cubas, Humberto García-Ortiz, Monserrat I. Morales-Rivera, Raigam Jafet Martínez-Portilla and Lorena Orozco
Antioxidants 2024, 13(12), 1564; https://doi.org/10.3390/antiox13121564 - 19 Dec 2024
Viewed by 382
Abstract
Endoplasmic reticulum stress (ERS) is activated in all cells by stressors such as hyperglycemia. However, it remains unclear which specific serum biomarkers of ERS are consistently altered in type 2 diabetes (T2D). We aimed to identify serum ERS biomarkers that are consistently altered [...] Read more.
Endoplasmic reticulum stress (ERS) is activated in all cells by stressors such as hyperglycemia. However, it remains unclear which specific serum biomarkers of ERS are consistently altered in type 2 diabetes (T2D). We aimed to identify serum ERS biomarkers that are consistently altered in T2D and its complications, and their correlation with metabolic and anthropometric variables. We performed a systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-Analyses and Systematic Reviews of Observational Studies (MOOSE). The risk of bias was assessed using the Newcastle–Ottawa scale. Random-effects models weighted by the inverse variance were employed to estimate the standardized mean difference and correlations as effect size measures. Indicators of heterogeneity and meta-regressions were evaluated. Of the 1206 identified studies, 22 were finally included, representing 11,953 subjects (2224 with T2D and 9992 non-diabetic controls). Most studies were of high quality. Compared with controls, subjects with T2D had higher circulating levels of heat shock protein 70 (HSP70; SMD: 2.30, 95% CI 1.13–3.46; p < 0.001) and secretagogin (SMD: 0.60, 95%CI 0.19–1.01; p < 0.001). They also had higher serum levels of peroxiredoxin-1, -2, -4, and -6. Secretagogin inversely correlated with HOMA-IR, yet positively correlated with HOMA-B, HbA1c, and FPG. PRX4 negatively correlated with HbA1c and FPG, while HSP70 positively correlated with HbA1c. In conclusion, six ERS biomarkers are consistently elevated in human T2D and correlate with glycemic control, insulin resistance, and β-cell function. Emerging evidence links serum ERS biomarkers to diabetes complications, but further research should evaluate their prognostic implications. Full article
Show Figures

Figure 1

Figure 1
<p>PRISMA flow diagram of the study.</p>
Full article ">Figure 2
<p>ERS biomarkers significantly increased in T2D. SD: standard deviation; SMD: standardized mean difference; CI: confidence interval. We highlighted in blue the 95% confidence intervals, in green the significant <span class="html-italic">p</span>-values, and in red those studies with I<sup>2</sup> [heterogeneity] greater than 40% [<a href="#B39-antioxidants-13-01564" class="html-bibr">39</a>,<a href="#B40-antioxidants-13-01564" class="html-bibr">40</a>,<a href="#B42-antioxidants-13-01564" class="html-bibr">42</a>,<a href="#B43-antioxidants-13-01564" class="html-bibr">43</a>,<a href="#B44-antioxidants-13-01564" class="html-bibr">44</a>,<a href="#B45-antioxidants-13-01564" class="html-bibr">45</a>,<a href="#B46-antioxidants-13-01564" class="html-bibr">46</a>,<a href="#B47-antioxidants-13-01564" class="html-bibr">47</a>,<a href="#B48-antioxidants-13-01564" class="html-bibr">48</a>,<a href="#B49-antioxidants-13-01564" class="html-bibr">49</a>].</p>
Full article ">Figure 3
<p>ERS biomarkers not significantly associated with T2D. SD: standard deviation; SMD: standardized mean difference; CI: confidence interval. We highlighted in blue the 95% confidence intervals, in orange the non-significant <span class="html-italic">p</span>-values, and in red those studies with I<sup>2</sup> [heterogeneity] greater than 40% [<a href="#B34-antioxidants-13-01564" class="html-bibr">34</a>,<a href="#B35-antioxidants-13-01564" class="html-bibr">35</a>,<a href="#B36-antioxidants-13-01564" class="html-bibr">36</a>,<a href="#B37-antioxidants-13-01564" class="html-bibr">37</a>,<a href="#B38-antioxidants-13-01564" class="html-bibr">38</a>,<a href="#B45-antioxidants-13-01564" class="html-bibr">45</a>,<a href="#B50-antioxidants-13-01564" class="html-bibr">50</a>].</p>
Full article ">Figure 4
<p>Forest plot of the sensitivity analysis for HSP70 and PRX4 shows the effect size’s consistency and discards outliers. SD: standard deviation; SMD: standardized mean difference; CI: confidence interval [blue] [<a href="#B44-antioxidants-13-01564" class="html-bibr">44</a>,<a href="#B45-antioxidants-13-01564" class="html-bibr">45</a>,<a href="#B46-antioxidants-13-01564" class="html-bibr">46</a>,<a href="#B47-antioxidants-13-01564" class="html-bibr">47</a>,<a href="#B48-antioxidants-13-01564" class="html-bibr">48</a>,<a href="#B49-antioxidants-13-01564" class="html-bibr">49</a>].</p>
Full article ">Figure 5
<p>The funnel plot and funnel plot with trim and fill for evaluating visual heterogeneity for HSP70.</p>
Full article ">Figure 6
<p>Components of the ERS pathway where HSP70, PRX and secretagogin participate. Stimuli like nutrient deprivation, oxidative stress, reactive oxygen species (ROS), insulin resistance, and hyperglycemia induce protein misfolding. Consequently, the machinery of the ERS is activated to counteract stress. Molecules such as peroxiredoxins, HSP, and secretagogin help to cope with ER stress and to refold misfolded or unfolded proteins. Peroxiredoxins help to refold proteins and contribute to glutathione biosynthesis, as well as antioxidant and chaperone defense. HSP-70 contributes to protein refolding, disintegration of protein aggregates, and the ubiquitination of misfolded proteins to degrade proteins in the proteasome. Meanwhile, SCGN facilitates protein folding, promotes insulin release, enhances β-cell survival and proliferation, and protects critical proteins like Pdx-1 from proteasomal degradation. ER: endoplasmic reticulum. Red circles indicate important molecules involved in ERS in T2D.</p>
Full article ">
13 pages, 800 KiB  
Article
Grape Pomace as a Source of Phenolics for the Inhibition of Starch Digestion Enzymes: A Comparative Study and Standardization of the Efficacy
by Pedapati Siva Charan Sri Harsha and Vera Lavelli
Foods 2024, 13(24), 4103; https://doi.org/10.3390/foods13244103 - 18 Dec 2024
Viewed by 358
Abstract
The increase in the incidence of hyperglycemia and diabetes poses the challenge of finding cost-effective natural inhibitors of starch digestion enzymes. Among natural compounds, phenolics have been considered as promising candidates. The aims of this study were as follows: (a) to investigate the [...] Read more.
The increase in the incidence of hyperglycemia and diabetes poses the challenge of finding cost-effective natural inhibitors of starch digestion enzymes. Among natural compounds, phenolics have been considered as promising candidates. The aims of this study were as follows: (a) to investigate the effectiveness of the inhibition of different winemaking byproducts towards intestinal brush border α-glucosidase and pancreatic α-amylase in vitro; (b) to calculate an efficacy index relative to the standard acarbose for the phenolic pool of winemaking byproducts, as well as for isolated phenolic compounds and for the phenolic pools of different plants studied in the literature, in order to rank winemaking byproducts with respect to the reference drug and other natural alternatives. Among winemaking byproducts, red grape skins showed the highest inhibitory activities towards both α-glucosidase and α-amylase, which were, on average, 4.9 and 2.6 µg acarbose equivalents/µg total phenolics (µg Ac eq/µg GAE), respectively. A correlation was observed between the total phenolic contents of red grape skins and their inhibitory effectiveness, which is useful for standardizing the efficacy of phenolic extracts obtained from different winemaking processes. In general, the inhibitory activity of the phenolic pool of grape skins was higher than those of isolated phenolic compounds, namely anthocyanins and monomeric and polymeric flavanols and flavonols, probably due to synergistic effects among compounds. Hence, bioactive phenolic fractions could be produced with the focus on functionality rather than purity, in line with the principles of sustainable processing. Based on the efficacy index developed to compare different phenolic compounds and phenolic-rich plants studied in the literature as starch digestion enzyme inhibitors, red grape skins proved to be cost-effective candidates. Full article
(This article belongs to the Section Food Nutrition)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Correlation between enzyme inhibition efficacy and phenolic content for red grape skins (<span style="color:#7030A0">▲</span>), white grape skins (<span style="color:#FFC000">♦</span>), and grape seeds (<span style="color:#00B050">●</span>). (<b>a</b>) α-glucosidase inhibition; (<b>b</b>) α-amylase inhibition. Data for grape seeds were recalculated from Lavelli et al., 2015 [<a href="#B27-foods-13-04103" class="html-bibr">27</a>].</p>
Full article ">Figure 2
<p>HPLC chromatograms of red skin extract. (<b>a</b>) Major peaks identified at 520 nm: 1. delphinidin–3–O–glucoside; 2. cyanidin–3–O–glucoside; 3. petunidin 3–O–glucoside; 4. peonidin–3–O–glucoside; and 5. malvidin–3-O–glucoside. (<b>b</b>) Major peaks identified at 354 nm: 1. quercetin glucoside; 2. quercetin; and 3. kaempferol. (<b>c</b>) Major peaks identified at λex 230/λem 320: 1. procyanidin B1; 2. catechin; 3. procyanidin B2; and 4. epicatechin.</p>
Full article ">
6 pages, 176 KiB  
Editorial
Diabetes: Recent Advances and Future Perspectives
by Miodrag Janić, Andrej Janež, Mohamed El-Tanani, Viviana Maggio and Manfredi Rizzo
Biomedicines 2024, 12(12), 2875; https://doi.org/10.3390/biomedicines12122875 - 18 Dec 2024
Viewed by 383
Abstract
Diabetes is a chronic metabolic disorder distinguished by persistent hyperglycemia [...] Full article
(This article belongs to the Section Endocrinology and Metabolism Research)
13 pages, 1874 KiB  
Article
Chronic Kidney Disease and Infection Risk: A Lower Incidence of Peritonsillar Abscesses in Specific CKD Subgroups in a 16-Year Korean Nationwide Cohort Study
by Mi Jung Kwon, Ho Suk Kang, Joo-Hee Kim, Ji Hee Kim, Woo Jin Bang, Dae Myoung Yoo, Na-Eun Lee, Kyeong Min Han, Nan Young Kim, Hyo Geun Choi, Min-Jeong Kim and Eun Soo Kim
Microorganisms 2024, 12(12), 2614; https://doi.org/10.3390/microorganisms12122614 - 18 Dec 2024
Viewed by 345
Abstract
Peritonsillar abscesses and deep neck infection are potentially serious infections among patients with chronic kidney disease (CKD), posing risks for severe complications and drawing significant public health concern. This nationwide, population-based longitudinal study (2002–2019) assessed the extended relationship between chronic kidney disease (CKD) [...] Read more.
Peritonsillar abscesses and deep neck infection are potentially serious infections among patients with chronic kidney disease (CKD), posing risks for severe complications and drawing significant public health concern. This nationwide, population-based longitudinal study (2002–2019) assessed the extended relationship between chronic kidney disease (CKD) and the likelihood of peritonsillar abscess and deep neck infection in a Korean cohort. Using a 1:4 propensity score overlap-weighted matching, we included 16,879 individuals with CKD and 67,516 comparable controls, accounting for demographic variables and comorbidities to ensure balanced group comparisons. Hazard ratios (HRs) and 95% confidence intervals (CIs) for deep neck infection and peritonsillar abscesses in relation to CKD history were calculated with a propensity score overlap-weighted Cox proportional hazards model. Our results revealed no significant increase in the overall incidence of deep neck infections or peritonsillar abscesses in CKD patients compared to controls. Interestingly, CKD patients demonstrated a 50% reduced likelihood of developing peritonsillar abscesses (HR 0.50; 95% CI = 0.30–0.83; p = 0.007), particularly among subgroups aged 70 years or older, females, non-smokers, rural residents, overweight individuals, and those with lower comorbidity burdens (e.g., absence of hypertension, hyperlipidemia, or hyperglycemia). In summary, the results suggest that lifestyle modifications and the effective management of comorbidities could reduce the risk of peritonsillar abscess in certain CKD subgroups. Our findings may help to alleviate public health concerns regarding peritonsillar abscesses and deep neck infections as CKD-related comorbidities. Full article
(This article belongs to the Special Issue Overview of Healthcare-Associated Infections)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>A visual overview of the participant selection and matching process in the study. Starting with the initial pool of 514,866 individuals in the Korean National Health Insurance Service-Health Screening Cohort (KNHIS-HSC) database, a meticulous selection process resulted in 16,879 patients diagnosed with chronic kidney disease being matched with 67,516 control participants. Matching was based on age, sex, income, and region of residence.</p>
Full article ">
18 pages, 3208 KiB  
Article
Vasculo-Protective Effects of Standardized Black Chokeberry Extracts in Mice Aorta
by Valentina Buda, Adrian Sturza, Daliana Minda, Zorița Diaconeasa, Cristian Iuhas, Bianca Bădescu, Cristina-Adriana Dehelean, Corina Danciu, Mirela-Danina Muntean, Rodica Lighezan and Maria-Daniela Dănilă
Int. J. Mol. Sci. 2024, 25(24), 13520; https://doi.org/10.3390/ijms252413520 - 17 Dec 2024
Viewed by 249
Abstract
Black chokeberry (Aronia melanocarpa <Michx.> Elliot) represents a rich source of dietary polyphenols and other bioactive phytochemicals with pleiotropic beneficial cardiovascular effects. The present study was aimed at evaluating the ex vivo effects of two black chokeberry extracts (BChEs), obtained from either [...] Read more.
Black chokeberry (Aronia melanocarpa <Michx.> Elliot) represents a rich source of dietary polyphenols and other bioactive phytochemicals with pleiotropic beneficial cardiovascular effects. The present study was aimed at evaluating the ex vivo effects of two black chokeberry extracts (BChEs), obtained from either dry (DryAr) or frozen (FrozAr) berries, on oxidative stress and vascular function in mice aortic rings after incubation with angiotensin 2 (Ang 2), lipopolysaccharide (LPS) and glucose (GLUC) in order to mimic renin–angiotensin system activation, inflammation and hyperglycemia. The identification of phenolic compounds was performed by means of liquid chromatography with a diode array detector coupled with mass spectrometry using the electrospray ionization interface. The BChE obtained from the FrozAr was rich in cyanidin glucoside, rutin and caffeic acid, while the one obtained from the dried berries was rich in rutin, caffeic acid and chlorogenic acid. Mice aortas were dissected and acutely incubated (12 h) with Ang2 (100 nM), LPS (1 µg/mL) or GLUC (400 mg/dL) in the presence vs. absence of the two BChEs (1, 10, 50, 75, 100, 500 µg/mL). Subsequently, the tissues were used for the assessment of (i) hydrogen peroxide (H2O2) and superoxide production (using two methods, spectrophotometry and immunofluorescence), (ii) H2O2 scavenger effect and (iii) vascular reactivity (using the organ bath/myograph system). After exposure to Ang2, LPS or GLUC, both types of extracts decreased the H2O2 and superoxide levels in a concentration-dependent manner starting from either 50 µg/mL or 100 µg/mL. Also, in the highest concentrations (100 µg/mL, 150 µg/mL and 500 µg/mL), both extracts elicited a significant scavenger effect on H2O2 (similar to catalase, the classic H2O2 scavenger). Moreover, at 100 µg/mL, both extracts were able to significantly improve vascular relaxation in all stimulated aortic rings. In conclusion, in mice aortas, black chokeberry extracts in acute application elicited a concentration-dependent vasculo-protective effect through the reduction of oxidative stress and the alleviation of endothelial dysfunction in ex vivo conditions that mimic cardio-metabolic diseases. Full article
Show Figures

Figure 1

Figure 1
<p>Effect of BChE on oxidative stress in mice aorta incubated (12 h) with Ang2 (100 nM). (<b>A</b>) DHE staining (one-way ANOVA, F = 37.69, <span class="html-italic">p</span> &lt; 0.0001); (<b>B</b>) FOX assay using BChE obtained from dried berries (DryAr; one-way ANOVA, F = 7.643 <span class="html-italic">p</span> &lt; 0.0001); (<b>C</b>) FOX assay using BChE obtained from frozen berries (FrozAr; one-way ANOVA, F = 4.909, <span class="html-italic">p</span> &lt; 0.0001). Tukey test, ns = non-significant, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001. n = 4.</p>
Full article ">Figure 2
<p>Effect of BChE on oxidative stress in mice aorta incubated (12 h) with LPS (1 pM). (<b>A</b>) DHE staining (one-way ANOVA, F = 42.43, <span class="html-italic">p</span> &lt; 0.0001); (<b>B</b>) FOX assay using BChE obtained from dried berries (DryAr; one-way ANOVA, F = 20.23, <span class="html-italic">p</span> &lt; 0.0001); (<b>C</b>) FOX assay using BChE obtained from frozen berries (FrozAr; one-way ANOVA, F = 14.21, <span class="html-italic">p</span> &lt; 0.0001). Tukey test, ns = non-significant, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001. n = 4.</p>
Full article ">Figure 3
<p>Effect of BChE on oxidative stress in mice aorta incubated (12 h) with high GLUC (22.2 mM). (<b>A</b>) DHE staining (one-way ANOVA, F = 57.54, <span class="html-italic">p</span> &lt; 0.0001); (<b>B</b>) FOX assay using BChE obtained from dried berries (DryAr; one-way ANOVA, F = 12.12, <span class="html-italic">p</span> &lt; 0.0001); (<b>C</b>) FOX assay using BChE obtained from frozen berries (FrozAr; one-way ANOVA, F = 8.217, <span class="html-italic">p</span> &lt; 0.0001). Tukey test, ns = non-significnat, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001. n = 4.</p>
Full article ">Figure 4
<p>Catalase-like scavenger effect of BCh extracts. (<b>A</b>) Dried berries (one-way ANOVA, F = 109.9, <span class="html-italic">p</span> &lt; 0.001); (<b>B</b>) frozen berries (one-way ANOVA, F = 296, <span class="html-italic">p</span> &lt; 0.001) (experiments run in triplicate). Cat—catalase, Tukey test, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 5
<p>Effects of BChE (100 µg/mL) on vascular relaxation in mice aortas incubated or not with Ang2 (100 nM, 12 h), LPS (1 pM, 12 h) or GLUC (22.2 mM, 12 h). One-way ANOVA: (<b>A</b>) F = 8.487, <span class="html-italic">p</span> = 0.0027; (<b>B</b>) F = 4.891, <span class="html-italic">p</span> = 0.0190; (<b>C</b>) F = 15.51, <span class="html-italic">p</span> = 0.0002; (<b>D</b>) F = 14.59, <span class="html-italic">p</span> = 0.0003; (<b>E</b>) F = 3.491, <span class="html-italic">p</span> = 0.05; (<b>F</b>) F = 3.488, <span class="html-italic">p</span> = 0.05. Tukey test, * <span class="html-italic">p</span> &lt; 0.05. n = 4.</p>
Full article ">
15 pages, 664 KiB  
Review
Corticosteroids in Pediatric Septic Shock: A Narrative Review
by Immacolata Rulli, Angelo Mattia Carcione, Federica D’Amico, Giuseppa Quartarone, Roberto Chimenz and Eloisa Gitto
J. Pers. Med. 2024, 14(12), 1155; https://doi.org/10.3390/jpm14121155 - 17 Dec 2024
Viewed by 316
Abstract
Objective: A controversial aspect of pediatric septic shock management is corticosteroid therapy. Current guidelines do not recommend its use in forms responsive to fluids and inotropes but leave the decision to physicians in forms refractory to the first steps of therapy. Data Sources: [...] Read more.
Objective: A controversial aspect of pediatric septic shock management is corticosteroid therapy. Current guidelines do not recommend its use in forms responsive to fluids and inotropes but leave the decision to physicians in forms refractory to the first steps of therapy. Data Sources: Review of literature from January 2013 to December 2023 from online libraries Pubmed, Medline, Cochrane Library, and Scopus. Study Selection: The keywords “septic shock”, “steroids” and “children” were used. Data Extraction: Of 399 articles, 63 were selected. Data Synthesis: Regarding mortality, although the 2019 Cochrane review supports reduced mortality, benefits on long-term mortality and in patients with CIRCI (critical illness-related corticosteroid insufficiency) are not clear. Yang’s metanalysis and retrospective studies of Nichols and Atkinson show no difference or even an increase in mortality. Regarding severity, the Cochrane review claims that hydrocortisone seems to reduce the length of intensive care hospitalization but influences the duration of ventilatory and inotropic support, and the degree of multi-organ failure appears limited. Further controversies exist on adrenal function evaluation: according to literature, including the Surviving Sepsis Campaign guidelines, basal or stimulated hormonal dosages do not allow the identification of patients who could benefit from hydrocortisone therapy (poor reproducibility). Regarding side effects, muscle weakness, hypernatremia, and hyperglycemia are the most observed. Conclusions: The literature does not give certainties about the efficacy of corticosteroids in pediatric septic shock, as their influence on primary outcomes (mortality and severity) is controversial. A subgroup of patients suffering from secondary adrenal insufficiency could benefit from it, but it remains to be defined how to identify and what protocol to use to treat them. Full article
(This article belongs to the Special Issue Optimizing Shock Treatments in Personalized Critical Care)
Show Figures

Figure 1

Figure 1
<p>Flowchart for included and excluded studies.</p>
Full article ">
Back to TopTop